{"pmid":32358232,"title":"Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A \"Living Working Document\".","text":["Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A \"Living Working Document\".","The severe acute respiratory syndrome (SARS)-CoV-2 is an emerging viral pathogen responsible for the global coronavirus disease 2019 (COVID)-19 pandemic resulting in significant human morbidity and mortality. Based on preliminary clinical reports, hypoxic respiratory failure complicated by acute respiratory distress syndrome is the leading cause of death. Further, septic shock, late-onset cardiac dysfunction, and multiorgan system failure are also described as contributors to overall mortality. Although extracorporeal membrane oxygenation and other modalities of mechanical cardiopulmonary support are increasingly being utilized in the treatment of respiratory and circulatory failure refractory to conventional management, their role and efficacy as support modalities in the present pandemic are unclear. We review the rapidly changing epidemiology, pathophysiology, emerging therapy, and clinical outcomes of COVID-19; and based on these data and previous experience with artificial cardiopulmonary support strategies, particularly in the setting of infectious diseases, provide consensus recommendations from ASAIO. Of note, this is a \"living document,\" which will be updated periodically, as additional information and understanding emerges.","ASAIO J","Rajagopal, Keshava","Keller, Steven P","Akkanti, Bindu","Bime, Christian","Loyalka, Pranav","Cheema, Faisal H","Zwischenberger, Joseph B","El Banayosy, Aly","Pappalardo, Federico","Slaughter, Mark S","Slepian, Marvin J","32358232"],"abstract":["The severe acute respiratory syndrome (SARS)-CoV-2 is an emerging viral pathogen responsible for the global coronavirus disease 2019 (COVID)-19 pandemic resulting in significant human morbidity and mortality. Based on preliminary clinical reports, hypoxic respiratory failure complicated by acute respiratory distress syndrome is the leading cause of death. Further, septic shock, late-onset cardiac dysfunction, and multiorgan system failure are also described as contributors to overall mortality. Although extracorporeal membrane oxygenation and other modalities of mechanical cardiopulmonary support are increasingly being utilized in the treatment of respiratory and circulatory failure refractory to conventional management, their role and efficacy as support modalities in the present pandemic are unclear. We review the rapidly changing epidemiology, pathophysiology, emerging therapy, and clinical outcomes of COVID-19; and based on these data and previous experience with artificial cardiopulmonary support strategies, particularly in the setting of infectious diseases, provide consensus recommendations from ASAIO. Of note, this is a \"living document,\" which will be updated periodically, as additional information and understanding emerges."],"journal":"ASAIO J","authors":["Rajagopal, Keshava","Keller, Steven P","Akkanti, Bindu","Bime, Christian","Loyalka, Pranav","Cheema, Faisal H","Zwischenberger, Joseph B","El Banayosy, Aly","Pappalardo, Federico","Slaughter, Mark S","Slepian, Marvin J"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358232","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1097/MAT.0000000000001180","topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1666138495323734016,"score":9.490897,"similar":[{"pmid":32357074,"title":"Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document.","text":["Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document.","The severe acute respiratory syndrome-CoV-2 is an emerging viral pathogen responsible for the global coronavirus disease 2019 pandemic resulting in significant human morbidity and mortality. Based on preliminary clinical reports, hypoxic respiratory failure complicated by acute respiratory distress syndrome is the leading cause of death. Further, septic shock, late-onset cardiac dysfunction, and multiorgan system failure are also described as contributors to overall mortality. Although extracorporeal membrane oxygenation and other modalities of mechanical cardiopulmonary support are increasingly being utilized in the treatment of respiratory and circulatory failure refractory to conventional management, their role and efficacy as support modalities in the present pandemic are unclear. We review the rapidly changing epidemiology, pathophysiology, emerging therapy, and clinical outcomes of coronavirus disease 2019; and based on these data and previous experience with artificial cardiopulmonary support strategies, particularly in the setting of infectious diseases, provide consensus recommendations from American Society for Artificial Internal Organs. Of note, this is a living document, which will be updated periodically, as additional information and understanding emerges.","Circ Heart Fail","Rajagopal, Keshava","Keller, Steven P","Akkanti, Bindu","Bime, Christian","Loyalka, Pranav","Cheema, Faisal H","Zwischenberger, Joseph B","El Banayosy, Aly","Pappalardo, Federico","Slaughter, Mark S","Slepian, Marvin J","32357074"],"abstract":["The severe acute respiratory syndrome-CoV-2 is an emerging viral pathogen responsible for the global coronavirus disease 2019 pandemic resulting in significant human morbidity and mortality. Based on preliminary clinical reports, hypoxic respiratory failure complicated by acute respiratory distress syndrome is the leading cause of death. Further, septic shock, late-onset cardiac dysfunction, and multiorgan system failure are also described as contributors to overall mortality. Although extracorporeal membrane oxygenation and other modalities of mechanical cardiopulmonary support are increasingly being utilized in the treatment of respiratory and circulatory failure refractory to conventional management, their role and efficacy as support modalities in the present pandemic are unclear. We review the rapidly changing epidemiology, pathophysiology, emerging therapy, and clinical outcomes of coronavirus disease 2019; and based on these data and previous experience with artificial cardiopulmonary support strategies, particularly in the setting of infectious diseases, provide consensus recommendations from American Society for Artificial Internal Organs. Of note, this is a living document, which will be updated periodically, as additional information and understanding emerges."],"journal":"Circ Heart Fail","authors":["Rajagopal, Keshava","Keller, Steven P","Akkanti, Bindu","Bime, Christian","Loyalka, Pranav","Cheema, Faisal H","Zwischenberger, Joseph B","El Banayosy, Aly","Pappalardo, Federico","Slaughter, Mark S","Slepian, Marvin J"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32357074","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1161/CIRCHEARTFAILURE.120.007175","keywords":["ards","coronavirus","extracorporeal membrane oxygenation","mechanical circulatory support","pandemic","shock"],"locations":["multiorgan"],"topics":["Treatment"],"weight":1,"_version_":1666138495260819456,"score":791.4761},{"pmid":32371555,"title":"Utility of extracorporeal membrane oxygenation in COVID-19.","text":["Utility of extracorporeal membrane oxygenation in COVID-19.","Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. Expert centers should employ an evidence-based ARDS treatment algorithm and a multidisciplinary approach to recommending ECMO upon failure of conventional therapy. Caring for ECMO patients requires adequate infection control and safety precautions for healthcare workers.","Cleve Clin J Med","Khan, Rizwan","Anandamurthy, Balaram","McCurry, Kenneth","Krishnan, Sudhir","32371555"],"abstract":["Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. Expert centers should employ an evidence-based ARDS treatment algorithm and a multidisciplinary approach to recommending ECMO upon failure of conventional therapy. Caring for ECMO patients requires adequate infection control and safety precautions for healthcare workers."],"journal":"Cleve Clin J Med","authors":["Khan, Rizwan","Anandamurthy, Balaram","McCurry, Kenneth","Krishnan, Sudhir"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371555","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3949/ccjm.87a.ccc014","topics":["Treatment"],"weight":1,"_version_":1666138496498139137,"score":216.28291},{"pmid":32307151,"pmcid":"PMC7161530","title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Rev Esp Anestesiol Reanim","Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C","32307151"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Rev Esp Anestesiol Reanim","authors":["Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307151","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.redar.2020.03.006","keywords":["aerosol-generating procedures","control de infeccion.","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138491176615936,"score":193.46463},{"pmid":32312600,"title":"Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","text":["Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Med Intensiva","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32312600"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Med Intensiva","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312600","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.medin.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138493449928705,"score":193.46463},{"pmid":32336563,"title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Arch Bronconeumol","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32336563"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Arch Bronconeumol","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336563","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.arbres.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138494176591872,"score":193.46463}]}